Mangoceuticals Inc. (MGRX)
NASDAQ: MGRX
· Real-Time Price · USD
1.63
0.05 (3.16%)
At close: Aug 15, 2025, 3:59 PM
1.55
-4.62%
After-hours: Aug 15, 2025, 04:03 PM EDT
Mangoceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 |
Net Income | -11.18M | -8.71M | -9.33M | -9.13M | -9.02M | -9.21M | -7.32M | -6.49M | -4.54M | -2M | -1.34M | -366.79K | -37.3K | -17.7K |
Depreciation & Amortization | 1.02M | 731.47K | 15.97K | 22.01K | 25.03K | 24.89K | 22.46K | 16.17K | 9.95K | 3.86K | n/a | n/a | n/a | n/a |
Stock-Based Compensation | 1.26M | 248.68K | 626.78K | 584.87K | 598.16K | 624.46K | 259.65K | 362.63K | 298.36K | 234.09K | 169.82K | n/a | n/a | n/a |
Other Working Capital | -37.93K | -36.36K | 9.02K | 35.17K | -50.79K | -70.57K | -35.9K | -68.01K | -24.34K | -6.13K | -62.05K | n/a | n/a | n/a |
Other Non-Cash Items | 3.86M | 2.21M | 2.96M | 2.3M | 1.63M | 1.91M | 1.07M | 1.25M | 1.1M | 398.58K | 494.86K | 227.65K | 1.07K | 181.00 |
Deferred Income Tax | n/a | n/a | -386.88K | -386.88K | -386.88K | -386.88K | -3.86K | -3.86K | -3.86K | -3.86K | n/a | n/a | n/a | n/a |
Change in Working Capital | -110.9K | 660.38K | 682.29K | 633.09K | 978.4K | 41.51K | 21.39K | 28.52K | -2.22K | 18.87K | -37.05K | 25K | n/a | n/a |
Operating Cash Flow | -6.15M | -4.86M | -5.43M | -5.98M | -6.18M | -7M | -5.95M | -4.84M | -3.14M | -1.35M | -714.48K | -114.13K | -36.23K | -17.52K |
Capital Expenditures | n/a | n/a | 3.52K | 3.52K | 3.52K | n/a | -44.09K | -46.62K | -46.62K | -43.1K | -2.53K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | 65K | 65K | 65K | 65K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 65K | 65K | 68.52K | 68.52K | 3.52K | n/a | -44.09K | -46.62K | -46.62K | -43.1K | -2.53K | n/a | n/a | n/a |
Debt Repayment | 62.5K | 150K | 187.5K | 187.5K | -1.7K | -89.2K | -89.2K | -114.2K | -70 | 49.93K | 89.2K | 114.2K | 89.27K | 39.27K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 3.79M | 1.5M | 1.5M | 1.5M | n/a | -78.26K | 421.24K | 396.24K | 396.24K | 474.5K | -25K | n/a | n/a | n/a |
Financial Cash Flow | 6.15M | 4.13M | 4.21M | 3.46M | 2.4M | 7.06M | 6.36M | 7.83M | 6.92M | 2.05M | 1.59M | 115K | 90.07K | 40.07K |
Net Cash Flow | 62.85K | -678.69K | -1.16M | -2.46M | -3.78M | 56.15K | 363.26K | 2.95M | 3.74M | 660.31K | 873.49K | 868.00 | 53.84K | 22.55K |
Free Cash Flow | -6.15M | -4.86M | -5.43M | -5.97M | -6.18M | -7M | -5.99M | -4.89M | -3.18M | -1.39M | -717.01K | -114.13K | -36.23K | -17.52K |